Acadia Pharmaceuticals reported $-33136000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
ALKERMES ALKS:US $ -15.07M 7.68M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bristol Myers Squibb BMY:US $ 5780M 8M
Cara Therapeutics CARA:US $ -4409000 23.44M
Corcept Therapeutics CORT:US $ 31.55M 4.49M
Cytokinetics CYTK:US $ -9.47M 67.05M
Eisai 4523:JP Y 17237M 28829M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
Johnson & Johnson JNJ:US $ 8036M 1273M
Marinus Pharmaceuticals MRNS:US $ -16.63M 10.4M
Moderna Inc MRNA:US 2.52B 1.78B
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Pfizer PFE:US $ 12921M 1739M
Prothena PRTA:US -43009000 5.26M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
YTE INCY:US $ 276.8M 132.69M